1. Home
  2. DRUG vs KELYB Comparison

DRUG vs KELYB Comparison

Compare DRUG & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

N/A

Current Price

$60.45

Market Cap

778.4M

Sector

Health Care

ML Signal

N/A

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

N/A

Current Price

$22.75

Market Cap

814.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
DRUG
KELYB
Founded
2019
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
778.4M
814.8M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
DRUG
KELYB
Price
$60.45
$22.75
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$129.25
N/A
AVG Volume (30 Days)
76.2K
4.6K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
1.95%
EPS Growth
N/A
N/A
EPS
N/A
0.15
Revenue
N/A
$5,355,600,000.00
Revenue This Year
N/A
$0.72
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$147.93
Revenue Growth
N/A
N/A
52 Week Low
$44.25
$8.38
52 Week High
$123.75
$125.00

Technical Indicators

Market Signals
Indicator
DRUG
KELYB
Relative Strength Index (RSI) 28.03 46.73
Support Level $56.47 $21.49
Resistance Level $78.35 $24.78
Average True Range (ATR) 2.92 0.88
MACD -1.28 -0.22
Stochastic Oscillator 4.75 45.76

Price Performance

Historical Comparison
DRUG
KELYB

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

Share on Social Networks: